News Releases
This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
11 16 2020 Collaboration will include COVID-19 IgG antibody testing for up to 1,000 study participantsBOSTON, NEW YORK, SECAUCUS, NJ- Nov. 16, 2020 - Today, Dana-Farber Cancer Institute, one of the world’s leading centers of cancer research and treatment, and Quest Diagnostics, (NYSE: DGX), the...
-
11 03 2020 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Credit Suisse 29th Annual Virtual...
-
10 27 2020 First collaboration of virtual care provider and national laboratory provider features self-collected at-home specimen collection and mental health care support to empower diverse workforces to access health care safelyQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Catapult Health, the leading national provider of employer-sponsored Preventive Checkups, have...
-
10 22 2020 - Third quarter revenues of $2.79 billion, up 42.5% from 2019Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the third quarter ended September 30, 2020....
-
10 15 2020 Largest nationally representative study based on laboratory data shows double-digit increases in mixing of fentanyl with amphetamines and cocaineA new Quest Diagnostics Health Trends study indicates that misuse of fentanyl, heroin and nonprescribed opioids are on the rise, potentially due to the COVID-19 pandemic's impact on healthcare...
-
10 15 2020 Quest Diagnostics Recognized for Offering One of the Nation's Best Workforce Health and Well-being Initiatives for Third Year in a RowQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has received the 2020 Best Employers: Excellence in Health & Well-Being...
-
10 13 2020 Qualified residents in close proximity to Cheektowaga Walmart may be able to receive at-home self-collection kits by drone deliveryCHEEKTOWAGA, NY – Oct. 13 –Walmart, Quest Diagnostics, and DroneUp today announced a pilot program to provide drone delivery of COVID-19 at-home self-collection kits to single-family homes in...
-
10 05 2020 Nationwide Collaboration Creates Multi-Layered Approach to Public Health SafetyToday, CLEAR, the secure identity company, and Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced a new collaboration that aims to foster...
-
09 30 2020 Nearly 20 Viral and Bacterial Infections Can Be Identified from a Single Swab, Reducing Time to Diagnose and TreatHealthcare providers across the United States can now access three different test options from Quest Diagnostics (NYSE: DGX) to aid the diagnosis of COVID-19 and differentiate it from other...
-
09 22 2020 Qualified residents in close proximity to North Las Vegas Walmart may be able to receive at-home self-collection kits by drone deliveryNORTH LAS VEGAS, NV – Sept. 22 –Walmart, Quest Diagnostics, and DroneUp today announced a pilot program to provide drone delivery of COVID-19 at-home self-collection kits to single-family...
09 17 2020 QuestDirect™ Active Infection allows individuals to collect a specimen at home or by drive-thru at more than 500 Walmart Neighborhood Market locationsIndividuals can now purchase a test to diagnose COVID-19 online, without visiting a doctor's office, through QuestDirect, the consumer-initiated testing business of Quest Diagnostics (NYSE: DGX),...
-
09 11 2020 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley 18th Annual Global...
-
09 10 2020 - Revenues for full year 2020 now expected to be $8.4-8.8 billion compared to the previous outlook of $8.0-8.6 billionQuest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, today updated its financial outlook for full year 2020. Since the company reported its...
-
09 02 2020 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Wells Fargo Virtual Healthcare...
08 25 2020 Marijuana positivity climbed by double digits across nearly all employee testing categories, while opiate and heroin positivity declineThe rate of workforce drug positivity hit a sixteen-year high in 2019, according to a new analysis released today by Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic...
-
08 24 2020 Quest to dedicate more than $100 million to expand access to testing, partner to help those hit hardest by COVID-19 and fund Foundation initiativesQuest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, and the Quest Diagnostics Foundation, today announced a wide-ranging initiative to...
-
08 18 2020 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.56 per share,...
-
08 12 2020 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, today released its Annual Environmental, Social & Governance Report for 2019. The...
08 03 2020 Next generation sequencing offers more comprehensive data on more commonly inherited health conditionsA new innovation in advanced genetic sequencing automation from Quest Diagnostics (NYSE: DGX) will now enable individuals to access highly accurate genetic testing providing insights into...
07 29 2020 Technique to increase COVID-19 molecular diagnostic testing capacity and provide faster test results reportingQuest Diagnostics (NYSE:DGX) today announced that the U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for a new laboratory technique that speeds the process...
-
07 23 2020 - Second quarter revenues of $1.83 billion, down 6.4% from 2019Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the second quarter ended June 30, 2020, which are...
07 18 2020 First FDA authorization of laboratory technique for use in COVID-19 diagnostic testingQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has received emergency use authorization (EUA) from the U.S. Food and Drug...
-
07 13 2020 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today preliminary financial results for the second quarter ended June 30,...
-
06 30 2020 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, marks its 10-year anniversary as a CEO Cancer Gold Standard™ employer this year, signifying its...
-
05 29 2020 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Jefferies Virtual Healthcare Conference....
-
05 29 2020 COVID-19 tests will be distributed each week to St. Louis area Federally Qualified Health CentersHome State Health announced a collaboration with Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, to increase access to real-time reverse...
05 28 2020 Company to make the device available through broad range of healthcare, state, employer and consumer-initiated channelsQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has received emergency use authorization (EUA) from the U.S. Food and Drug...
05 27 2020 COVID-19 molecular diagnostic and serology antibody testing at core of new suite of servicesQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today launched a new suite of Return to Work services built around large-scale workforce COVID-19...
-
05 20 2020 TRENTON – Governor Phil Murphy, Walmart, and Quest Diagnostics today announced that seven Walmart stores across New Jersey will open COVID-19 drive-thru testing sites beginning on May 22. The...
-
05 20 2020 1,000 COVID-19 test kits will be distributed each week to Federally Qualified Health Centers in ArkansasArkansas Health & Wellness and Arkansas Total Care announced today a collaboration with Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, to increase...
-
05 18 2020 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.56 per share,...
-
05 11 2020 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today the pricing of a public offering of $550 million aggregate principal...
-
05 08 2020 1,000 COVID-19 test kits will be distributed each week to Federally Qualified Health Centers in GeorgiaATLANTA, GA – Peach State Health announced today a collaboration with Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, to increase access to...
-
05 05 2020 Quest Diagnostics Incorporated (NYSE: DGX) today announced that its 2020 Annual Meeting of Stockholders (the "Annual Meeting") will now be held solely by remote communication through a live,...
-
04 29 2020 Company to join forces with Quest Diagnostics to expand access to COVID-19 testing at critical safety net providers across the countryCentene (NYSE: CNC) announced today a collaboration with Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, to increase access to real-time reverse...
04 28 2020 Provides physician-guided insight into COVID-19 immune response without a visit to the doctorBeginning today, individuals can purchase COVID-19 antibody testing for themselves online, without visiting a doctor's office, through QuestDirect, the consumer-initiated testing business of Quest...
-
04 22 2020 - First quarter revenues of $1.82 billion, down 3.7% from 2019Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the first quarter ended March 31, 2020. "We were...
04 21 2020 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has begun to perform antibody testing for coronavirus (COVID-19) using blood...
-
04 09 2020 CareDx Collaborates with ExamOne, a Quest Diagnostics Company, to Expand Mobile Phlebotomy Coverage Across the United States for Transplant Patients who are High Risk for COVID-19SOUTH SAN FRANCISCO, Calif., April 09, 2020 -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically...
-
04 07 2020 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 2020 results on Wednesday, April 22, 2020,...
-
03 21 2020 Individuals Who are 60 Years or Older or Who Have Other High-Risk Factors for Adverse COVID-19 Outcomes to Receive VIP Access During First Hour of Each DayThrough its "Peace of Mind" program, Quest Diagnostics (NYSE: DGX) is taking extra measures to ensure individuals who are the most vulnerable to adverse COVID-19 outcomes have special VIP-level...
03 05 2020 Aim of new service is to supplement public health response in the United StatesQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it will launch a coronavirus (COVID-19) test service. The new test service aids the...